GILD
Gilead Sciences
Stock NASDAQ – Stock Market Prices, News & Analysis
Gilead Sciences is an American biopharmaceutical company specializing in the research, development, and commercialization of antiviral drugs for the treatment of HIV, hepatitis B and C, as well as other infectious diseases.
Gilead Sciences
GILD
Gilead Sciences is an American biopharmaceutical company specializing in the research, development, and commercialization of antiviral drugs for the treatment of HIV, hepatitis B and C, as well as other infectious diseases.
Price history of Gilead Sciences
Price history of Gilead Sciences
Performance & Momentum
Strategic Analysis
Gilead Sciences • 2026
Gilead Sciences positions itself as a major player in biotechnology in the United States, specializing in antivirals for key infectious diseases such as HIV and hepatitis. Its strategy relies on continuous innovation in R&D and a strong presence in therapeutic segments with high medical need.
Strengths
- Strong portfolio of proven antiviral drugs in critical niche markets
- Ability for scientific innovation and adaptation to therapeutic developments
- History of robust financial performance over the medium and long term
Weaknesses
- Significant reliance on a few iconic therapeutic segments, limiting diversification
- Regulatory pressures and increasing competition in the biopharmaceutical sector
Momentum
The momentum shows a positive trend supported by regular growth in the stock price over multiple horizons, reflecting investor confidence in its ability to maintain its leading position. This trend suggests considering Gilead for a stability-oriented and innovation-focused health portfolio.
Similar stocks to Gilead Sciences
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
